Back
ESC2025 Premium Access

Effects of icosapent ethyl on risk and duration of hospitalizations and death in REDUCE-IT

Session: Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?
Topic: Cardiovascular Pharmacotherapy
Speaker: Professor D. Bhatt (New York, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)
52 presentations
12 followers

4 more presentations in this session

State-of-the-art lecture on closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Speaker: Professor D. Bhatt (New York, US)

Access
Slides
Video
Like
Thumbnail

Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis

Speaker: Professor S. Mulvagh (Halifax, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF

Speaker: Doctor R. Aggarwal (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Undertreatment of women with lipid-lowering therapies in four European countries: results from the prospective, non-interventional MILOS Study

Speaker: Professor I. Gouni-Berthold (Cologne, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Speakers: Professor D. Bhatt, Professor D. Bhatt, Professor S. Mulvagh, Doctor R. Aggarwal, Professor I. Gouni-Berthold
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources